Drugs have long been used to enhance our health and extend lives. However, in many instances, it is very difficult to administer drugs to the part of the body where it is needed. For example, it is very hard to administer chemotherapy drugs to the patients with pancreatic cancer, because the pancreas is located deep within the abdomen. Scientists are continuously working to solve this problem. From implantable devices to smart capsules, drug manufacturers are regularly coming up with new ideas of drug delivery. At our WT | Wearable Technologies Conference in San Francisco July 11-12 we will highlight great thought leaders and innovators from all over the globe. While these innovators will be speaking at the conference, the companies themselves will showcase their breakthrough innovations. The companies and their leaders speaking at the conference are listed below. Do not miss the chance to meet and listen to them in person and join us for #WTUS18!
TracPatch is a new revolutionary device empowering at-home patient recovery and remote monitoring for effective managed care. With a focus on evidence-based medicine, TracPatch is changing patient care and the future of orthopedics. When Consensus Orthopedics found a common drawback in orthopedic surgery: a minimal connection between surgeons and patients, it set out to solve the problem, and created TracPatch. TracPatch monitors key patient metrics allowing a surgeon to remotely monitor a patient’s recovery. It utilizes smartphone technology and Internet of Things (IoT). Healthcare providers can now engage patients every day during their episode of care. Patients feel empowered to reach their recovery goals.
Dr. Chris Leslie, Chief Medical Director at Consensus Orthopedics, will be speaking at our WT | Wearable Technologies Conference in San Francisco. Dr. Leslie will discuss “Making Every Orthopedic Implant Smart: The Future of Orthopedics.”
Delta Idemo Lab Bridges the gap between technology and design by focusing on the important early stages of the design process and strive to create meaningful experiences for users and customers. IdemoLab uses electronics as a design material and explores the properties of electronics, merging them with traditional design materials to explore new possibilities. The Idemo Lab team specializes in facilitating and creating innovation for technological solutions. Delta Idemo Lab provides solutions for: Internet of Things (IoT), Batteryless and Self-powered electronics, Designing smart things and Retail technology.
Vanessa Carpenter, Technology Experience Designer at Idemo Lab, will be speaking at our WT | Wearable Technologies Conference in San Francisco. She will discuss “How to design for meaningfulness in wearables.”
etectRx is a pre-market medical device company that is developing an ingestible event marker (the ID-Cap™ System) that potentially gives clinicians the ability to accurately monitor patients’ medication adherence on a per-dose basis. The ID-Cap is a standard hard gelatin or HPMC capsule with an embedded ingestible wireless sensor – the ID-Tag™. Each time an ID-Cap is swallowed, the ID-Tag uses etectRx’s proprietary communications technology to transmit a very low power digital message from within the patient’s stomach. The App communicates with cloud-based software which stores the ingestion confirmation messages and allows the pharmacist or clinician to better manage the patients’s medication adherence. It looks, tastes and feels just like an ordinary capsule. One or two-way communication between the ID-Tag and the Reader ensures every ingestion is detected. The ID-Tag communications technology has demonstrated high reliability in multiple clinical studies. The ID-Tag is powered by the patient’s own stomach fluids. After the capsule dissolves, the ultra-thin, flexible sensor is naturally eliminated through the patient’s GI tract.
Harry Travis, President & CEO or etectRx will be speaking at our WT | Wearable Technologies Conference in San Francisco. She will discuss. Harry will discuss “From Apps to ingestible sensors, how digital tech can solve America’s $300 billion medication adherence problem.”
Rani Therapeutics has developed an innovative approach for the oral delivery of large drug molecules including proteins, peptides and antibodies. The pill delivers an intestinal injection without exposing the drug to digestive enzymes. The patient takes what seems to be an ordinary capsule, but the “robotic” pill is a sophisticated device which incorporates a number of innovations, enabling it to navigate through the stomach and enter the small intestine. The Rani Pill™ goes through a transformation and positions itself to inject the drug into the intestinal wall.
Mir Imran, Chairman & CEO of Rani Therapeutics, who will be speaking at the WT | Wearable Technologies Conference in San Francisco on July 11-12. Mr. Imran will discuss “The Future of Biologics Delivery.”
